These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4377076)

  • 1. [Proceedings: Anomalies in the regulation of the secretion of corticotropin in chromophobe adenomas].
    Lucas C; Olivier C; Jaquet P; Vague J
    Ann Endocrinol (Paris); 1974; 35(5):595. PubMed ID: 4377076
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anomalies of corticotropin secretion in chromophobe adenomas].
    Lucas C; Oliver Ch; Jaquet Ph; Vague J
    Ann Endocrinol (Paris); 1975; 36(4):179-84. PubMed ID: 173237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum thyrotropin (TSH) in pituitary and-or hypothalamic hypothyroidism: normal or elevated basal levels and paradoxical responses to thyrotropin-releasing hormone.
    Patel YC; Burger HG
    J Clin Endocrinol Metab; 1973 Aug; 37(2):190-6. PubMed ID: 4352630
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endocrinological evaluation of sellar and suprasellar tumor cases --the first report-- on preoperative pituitary function (author's transl)].
    Uozumi T; Mori S; Watanabe M; Takimoto N; Mogami H
    No Shinkei Geka; 1974 May; 2(5):389-84. PubMed ID: 4373675
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged and exaggerated elevations in plasma thyrotropin (HTSH) after thyroptropin releasing factor (TRF) in patients with pituitary tumors.
    Faglia G; Beck Peccoz P; Ambrosi B; Ferrari C; Neri V
    J Clin Endocrinol Metab; 1971 Dec; 33(6):999-1002. PubMed ID: 5002719
    [No Abstract]   [Full Text] [Related]  

  • 6. An FSH and prolactin-secreting pituitary tumor: pituitary dynamics and testicular histology.
    Cunningham GR; Huckins C
    J Clin Endocrinol Metab; 1977 Feb; 44(2):248-53. PubMed ID: 402377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pituitary and primary hypothyroidism. Enlargement and unusual growth hormone secretory responses.
    Lawrence AM; Wilber JF; Hagen TC
    Arch Intern Med; 1973 Sep; 132(3):327-33. PubMed ID: 4361212
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormones in human pituitary sinusoid blood: concentration of LH, GH and TSH.
    Conway LW; Schalch DS; Utiger RD; Reichlin S
    J Clin Endocrinol Metab; 1969 Apr; 29(4):446-56. PubMed ID: 4305278
    [No Abstract]   [Full Text] [Related]  

  • 9. [Human growth hormone estimations in the differential diagnosis of chromophobe and eosinophil pituitary adenomas].
    Nieschlag E; Wombacher H; Kroeger FJ; Overzier C
    Klin Wochenschr; 1971 Oct; 49(20):1138-43. PubMed ID: 4330700
    [No Abstract]   [Full Text] [Related]  

  • 10. Disorders of growth hormone and corticotropin regulation in patients with empty sella.
    Faglia G; Ambrosi B; Beck-Peccoz P; Giovanelli M
    J Neurosurg; 1973 Jan; 38(1):59-64. PubMed ID: 4345170
    [No Abstract]   [Full Text] [Related]  

  • 11. Pituitary tumors.
    Ciric I
    Neurol Clin; 1985 Nov; 3(4):751-68. PubMed ID: 2867459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine function in patients with untreated chromophobe adenomas.
    Nieman EA; Landon J; Wynn V
    Q J Med; 1967 Jul; 36(143):357-92. PubMed ID: 4167451
    [No Abstract]   [Full Text] [Related]  

  • 13. [TSH, HGH, ACTH, LH plasma levels in patients with pituitary disease (author's transl)].
    Jaquet P; Kolaszynski Y; Oliver C; Djian R; Vague J
    Ann Endocrinol (Paris); 1973; 34(3):283-5. PubMed ID: 4356379
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevations in plasma growth hormone concentration after luteinizing hormone-releasing hormone (LRH) in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Travaglini P; Paracchi A; Spada A; Lewin A
    J Clin Endocrinol Metab; 1973 Aug; 37(2):338-40. PubMed ID: 4198260
    [No Abstract]   [Full Text] [Related]  

  • 15. Human fetal pituitary in culture: hormone secretion and response to somatostatin, luteinizing hormone releasing factor, thyrotropin releasing factor and dibutyryl cyclic AMP.
    Goodyer CG; Hall CS; Guyda H; Robert F; Giroud CJ
    J Clin Endocrinol Metab; 1977 Jul; 45(1):73-85. PubMed ID: 194915
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problem of classification of pituitary adenomas (review of the foreign literature)].
    Kasumova SIu
    Zh Vopr Neirokhir Im N N Burdenko; 1978; (5):47-55. PubMed ID: 213917
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypothalamic control of adenohypophysial secretions.
    Blackwell RE; Guillemin R
    Annu Rev Physiol; 1973; 35():357-90. PubMed ID: 4350616
    [No Abstract]   [Full Text] [Related]  

  • 18. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proceedings: Hormone secretion in pituitary chromophobe adenoma].
    Yoshida J; Kobayashi T; Kageyama N
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):276. PubMed ID: 4476392
    [No Abstract]   [Full Text] [Related]  

  • 20. Initial evaluation and management of patients with suspected pituitary tumors.
    May PB
    Prim Care; 1977 Mar; 4(1):89-125. PubMed ID: 193138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.